Table 3.
Outcomes from Phase 2: CPAP vs. BiFLEX
| BiFLEX | CPAP | |
|---|---|---|
| N | 51 | 53 |
| Age (y) | 51.9 ± 11.3 | 52.5 ± 12.5 |
| Male (%) | 65 | 72 |
| Bmi (kg/m2) | 33.4 ± 7.9 | 32.6 ± 6.3 |
| Previous AHI (events/h) | 40.4 ± 23.4 | 44.0 ± 26.1 |
| Recommended cpap (Cm h2o) | 9.2 ± 2.9 | 9.1 ± 2.6 |
| Recommended BiFLEX (inspiratory/Expiratory pressure - cm h2o) | 10.9 ± 2.3/6.9 ± 2.1 | 11.0 ± 2.8/7.2 ± 2.5 |
| # Using ≥4 h/day (%) | 25 (49%) * | 15 (28%) |
| Daily use (h/day) | 3.7 ± 2.0 * | 2.9 ± 2.3 |
| % Days used during phase 2 | 70.9 ± 23.2 | 63.5 ± 35.0 |
| Increased daily use from phase 1 (h/day) | 1.7 ± 1.7 * | 1.1 ± 2.1 |
| Daily use (h/day) in therapy compliant subgroups | 5.4 ± 1.1 | 5.7 ± 1.2 |
Values are mean ± standard deviation.
*
p < 0.05